Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 19923 | 23.975 |
09:34 ET | 1800 | 24 |
09:36 ET | 1785 | 24.02 |
09:38 ET | 600 | 24.09 |
09:39 ET | 1249 | 24.14 |
09:41 ET | 1300 | 24.2 |
09:43 ET | 3546 | 24.14 |
09:45 ET | 1119 | 24.16 |
09:48 ET | 200 | 24.173 |
09:50 ET | 2430 | 24.17 |
09:52 ET | 1506 | 24.14 |
09:54 ET | 600 | 24.06 |
09:56 ET | 3485 | 24.09 |
09:57 ET | 993 | 24.07 |
09:59 ET | 1300 | 24.08 |
10:01 ET | 12270 | 24.11 |
10:03 ET | 15925 | 24.15 |
10:06 ET | 2350 | 24.15 |
10:08 ET | 4011 | 24.145 |
10:10 ET | 14096 | 24.2 |
10:12 ET | 3485 | 24.18 |
10:14 ET | 200 | 24.18 |
10:15 ET | 1788 | 24.15 |
10:17 ET | 6465 | 24.155 |
10:19 ET | 2205 | 24.16 |
10:21 ET | 3957 | 24.16 |
10:24 ET | 1983 | 24.19 |
10:26 ET | 5768 | 24.175 |
10:28 ET | 2540 | 24.18 |
10:30 ET | 742 | 24.19 |
10:32 ET | 4048 | 24.15 |
10:33 ET | 700 | 24.16 |
10:35 ET | 400 | 24.16 |
10:37 ET | 2717 | 24.1501 |
10:39 ET | 16668 | 24.135 |
10:42 ET | 2145 | 24.15 |
10:44 ET | 4250 | 24.15 |
10:46 ET | 2338 | 24.165 |
10:48 ET | 6252 | 24.16 |
10:50 ET | 2397 | 24.17 |
10:51 ET | 1915 | 24.17 |
10:53 ET | 2386 | 24.17 |
10:55 ET | 7635 | 24.175 |
10:57 ET | 2440 | 24.18 |
11:00 ET | 1000 | 24.185 |
11:02 ET | 8873 | 24.195 |
11:04 ET | 200 | 24.195 |
11:06 ET | 30206 | 24.21 |
11:08 ET | 300 | 24.215 |
11:09 ET | 10646 | 24.215 |
11:11 ET | 300 | 24.21 |
11:13 ET | 100 | 24.215 |
11:15 ET | 3241 | 24.23 |
11:18 ET | 3692 | 24.245 |
11:20 ET | 5648 | 24.215 |
11:22 ET | 17956 | 24.175 |
11:24 ET | 300 | 24.175 |
11:26 ET | 18109 | 24.19 |
11:27 ET | 400 | 24.195 |
11:29 ET | 600 | 24.195 |
11:31 ET | 9321 | 24.2 |
11:33 ET | 1300 | 24.205 |
11:36 ET | 9653 | 24.18 |
11:38 ET | 537 | 24.17 |
11:40 ET | 9875 | 24.17 |
11:42 ET | 1450 | 24.175 |
11:44 ET | 3255 | 24.175 |
11:45 ET | 5974 | 24.18 |
11:47 ET | 1730 | 24.185 |
11:49 ET | 3099 | 24.19 |
11:51 ET | 5768 | 24.15 |
11:54 ET | 7892 | 24.165 |
11:56 ET | 1600 | 24.17 |
11:58 ET | 1855 | 24.18 |
12:00 ET | 2813 | 24.175 |
12:02 ET | 1314 | 24.18 |
12:03 ET | 1400 | 24.185 |
12:05 ET | 6825 | 24.165 |
12:07 ET | 100 | 24.165 |
12:09 ET | 400 | 24.16 |
12:12 ET | 1753 | 24.16 |
12:14 ET | 100 | 24.165 |
12:16 ET | 3006 | 24.175 |
12:18 ET | 10806 | 24.145 |
12:20 ET | 893 | 24.145 |
12:21 ET | 4693 | 24.155 |
12:25 ET | 11084 | 24.14 |
12:27 ET | 4736 | 24.165 |
12:30 ET | 206 | 24.165 |
12:32 ET | 11975 | 24.19 |
12:34 ET | 6674 | 24.15 |
12:36 ET | 600 | 24.155 |
12:38 ET | 2156 | 24.155 |
12:39 ET | 7958 | 24.16 |
12:41 ET | 2391 | 24.17 |
12:43 ET | 3325 | 24.18 |
12:45 ET | 1208 | 24.19 |
12:48 ET | 1451 | 24.185 |
12:50 ET | 4445 | 24.18 |
12:52 ET | 4125 | 24.18 |
12:54 ET | 5131 | 24.19 |
12:56 ET | 3844 | 24.185 |
12:57 ET | 3058 | 24.17 |
12:59 ET | 2100 | 24.175 |
01:01 ET | 1476 | 24.175 |
01:03 ET | 13650 | 24.16 |
01:06 ET | 877 | 24.165 |
01:08 ET | 2200 | 24.155 |
01:10 ET | 800 | 24.155 |
01:12 ET | 7024 | 24.14 |
01:14 ET | 4136 | 24.145 |
01:15 ET | 2400 | 24.145 |
01:17 ET | 2300 | 24.145 |
01:19 ET | 300 | 24.145 |
01:21 ET | 29241 | 24.155 |
01:24 ET | 3833 | 24.15 |
01:26 ET | 1392 | 24.154 |
01:28 ET | 400 | 24.15 |
01:30 ET | 2873 | 24.16 |
01:32 ET | 2560 | 24.15 |
01:33 ET | 945 | 24.155 |
01:35 ET | 6825 | 24.135 |
01:37 ET | 2337 | 24.135 |
01:39 ET | 7257 | 24.16 |
01:42 ET | 3541 | 24.17 |
01:44 ET | 48934 | 24.165 |
01:46 ET | 11343 | 24.15 |
01:48 ET | 420 | 24.15 |
01:50 ET | 100 | 24.14 |
01:51 ET | 2000 | 24.145 |
01:53 ET | 6392 | 24.09 |
01:55 ET | 3857 | 24.07 |
01:57 ET | 898 | 24.075 |
02:00 ET | 12193 | 24.1 |
02:02 ET | 5497 | 24.08 |
02:04 ET | 1808 | 24.065 |
02:06 ET | 5912 | 24.085 |
02:08 ET | 3551 | 24.095 |
02:09 ET | 774 | 24.1 |
02:11 ET | 5700 | 24.1 |
02:13 ET | 2709 | 24.11 |
02:15 ET | 3232 | 24.12 |
02:18 ET | 5586 | 24.115 |
02:20 ET | 1253 | 24.12 |
02:22 ET | 7328 | 24.12 |
02:24 ET | 17241 | 24.07 |
02:26 ET | 10040 | 24.06 |
02:27 ET | 1487 | 24.06 |
02:29 ET | 2770 | 24.06 |
02:31 ET | 3933 | 24.095 |
02:33 ET | 3537 | 24.1053 |
02:36 ET | 4845 | 24.11 |
02:38 ET | 2724 | 24.105 |
02:40 ET | 2271 | 24.12 |
02:42 ET | 6513 | 24.115 |
02:44 ET | 3974 | 24.15 |
02:45 ET | 5840 | 24.15 |
02:47 ET | 5776 | 24.14 |
02:49 ET | 3101 | 24.15 |
02:51 ET | 2234 | 24.16 |
02:54 ET | 4978 | 24.15 |
02:56 ET | 2539 | 24.135 |
02:58 ET | 2767 | 24.14 |
03:00 ET | 8869 | 24.14 |
03:02 ET | 1544 | 24.16 |
03:03 ET | 3914 | 24.13 |
03:05 ET | 2450 | 24.14 |
03:07 ET | 2821 | 24.14 |
03:09 ET | 1349 | 24.14 |
03:12 ET | 2384 | 24.145 |
03:14 ET | 7411 | 24.14 |
03:16 ET | 3724 | 24.14 |
03:18 ET | 2848 | 24.15 |
03:20 ET | 5964 | 24.145 |
03:21 ET | 8308 | 24.135 |
03:23 ET | 7200 | 24.09 |
03:25 ET | 5318 | 24.13 |
03:27 ET | 3228 | 24.14 |
03:30 ET | 3900 | 24.14 |
03:32 ET | 11009 | 24.15 |
03:34 ET | 3010 | 24.15 |
03:36 ET | 12168 | 24.15 |
03:38 ET | 4959 | 24.16 |
03:39 ET | 2055 | 24.16 |
03:41 ET | 16401 | 24.12 |
03:43 ET | 8135 | 24.12 |
03:45 ET | 10228 | 24.115 |
03:48 ET | 7014 | 24.13 |
03:50 ET | 11475 | 24.115 |
03:52 ET | 19707 | 24.085 |
03:54 ET | 26561 | 24.095 |
03:56 ET | 34747 | 24.045 |
03:57 ET | 46155 | 24.055 |
03:59 ET | 328441 | 24.02 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 6.9x | --- |
Exelixis Inc | 6.0B | 31.8x | -21.77% |
PTC Therapeutics Inc | 2.9B | -4.8x | --- |
Novavax Inc | 2.2B | -4.9x | --- |
P3 Health Partners Inc | 186.5M | -1.0x | --- |
Halozyme Therapeutics Inc | 5.6B | 18.1x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.44 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.9x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.1x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.